...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Kidneys from Older Living Donors Provide Excellent Short and Intermediate Outcomes-A Single China Center's Experience
【24h】

Kidneys from Older Living Donors Provide Excellent Short and Intermediate Outcomes-A Single China Center's Experience

机译:老年捐赠者的肾脏可提供出色的短期和中期结果-单一中国中心的经验

获取原文
获取原文并翻译 | 示例

摘要

Background. Transplantation with kidneys from older living donors is on the rise, yet controversy still exists over whether the outcomes are as satisfactory as with kidneys from younger donors. Methods. We retrospectively analyzed 1009 living donor kidney transplants performed at our center between 2006 and 2013. Graft and patient outcomes were compared between transplants with kidneys from old living donors (OLD, 55-65 years) (n = 264) and from young living donors (YLD, < 55 years) (n = 745). Results. The age was 32.80 +/- 9.71 years and 33.91 +/- 5.98 years for recipient in YLD and OLD group, respectively. Death-censored graft survival at 1, 3, and 5 years was 98.8%, 97.1%, and 95.8% in patients receiving YLD kidneys, similar to the corresponding values of 97.6%, 95.5% and 95.5% in patients receiving OLD kidneys (P = 0.356). Patient survival at 1, 3, and 5 years after transplantation was also similar for patients receiving YLD kidneys (98.5%, 97.1%, and 96.7%) and for patients receiving OLD kidneys (99.6%, 99.6%, and 96.8%; P = 0.110). The OLD kidneys were not associated with increased risk of death-censored graft failure (hazard ratio, 2.5; 95% confidence interval, 0.57 to 11.11) and patient death (hazard ratio, 1.67; 95% confidence interval, 0.75 to 3.73). In addition, there is no increased graft loss or patient death for each 10-year increase in donor age. Transplantation with OLD kidneys was not associated with reduced patient or graft outcomes in the short term (<= 12 months) or medium term (> 1 year). Conclusions. Graft and patient outcomes after living-donor kidney transplantation are similar in the short-term and medium-term for donors aged 55 to 65 years and for younger donors. Therefore, the use of OLD kidneys should be encouraged in China.
机译:背景。来自年龄较大的活体供者的肾脏的移植正在增加,但是关于结果是否与来自年龄较小的供体的肾脏的令人满意的争议仍然存在。方法。我们回顾性分析了2006年至2013年间在我们中心进行的1009例活体供体肾脏移植。比较了年龄较大的活体供体(55-65岁)(n = 264)和年轻的活体供体(n = 264)的移植和患者预后。 YLD,<55岁)(n = 745)。结果。 YLD和OLD组的接受者年龄分别为32.80 +/- 9.71岁和33.91 +/- 5.98岁。接受YLD肾脏治疗的患者在1、3和5年时以死亡为依据的移植物存活率为98.8%,97.1%和95.8%,与接受老肾脏治疗的患者的97.6%,95.5%和95.5%的相应值相似(P = 0.356)。接受YLD肾移植的患者(98.5%,97.1%和96.7%)和接受老年肾移植的患者(99.6%,99.6%和96.8%)在移植后1年,3年和5年的患者存活率也相似; P = 0.110)。老肾与以死亡检查的移植物衰竭(风险比为2.5; 95%置信区间为0.57至11.11)和患者死亡(风险比为1.67; 95%置信区间为0.75至3.73)的风险增加无关。此外,供体年龄每增加10年,移植物损失或患者死亡均不会增加。在短期(<= 12个月)或中期(> 1年)内,使用旧肾脏移植与患者或移植物结局的降低无关。结论。 55至65岁的供体和较年轻的供体在短期和中期的活体供体肾移植后的移植物和患者预后相似。因此,在中国应该鼓励使用老年肾脏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号